D-0618-2020 Class III Terminated

Recalled by Glenmark Pharmaceuticals Inc., USA — Mahwah, NJ

FDA drug recall D-0618-2020 was initiated by Glenmark Pharmaceuticals Inc., USA on Nov 15, 2019 and is designated Class III. Reason for recall: Defective delivery system; product is not foaming or is coming out as liquid. The recall status is terminated (terminated Mar 15, 2024). Affected quantity: a) 34521 bottles; b) 16930 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 18, 2019
Initiation Date
Nov 15, 2019
Termination Date
Mar 15, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 34521 bottles; b) 16930 bottles

Product description

Clobetasol Propionate Foam, 0.05%, a) 50 g pack (NDC 68462-608-27) and b) 100 g pack (NDC 68462-608-94), Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd. Plot No.: B-25, MIDC, Shendra Aurangabad - 431210, Maharashtra, India Manufactured for: Glenmark Pharmaceuticas Inc. USA Mahwah, NJ 07430

Reason for recall

Defective delivery system; product is not foaming or is coming out as liquid.

Distribution pattern

Nationwide

Code information

a) 14190026, 14190028, 14190029, exp Feb-2021, 14190043, 14190045 exp Apr-2021 b) 14190024, 14190025, 14190027, exp Feb-2021, 14190030, 14190031, exp Mar-2021, 14190039, 14190042 exp Apr-2021, 14190047 exp May-2021, 14190062 exp Jul-2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0618-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0618-2020. Report a data issue: hello@regdatalab.com.